STOCK TITAN

MultiSensor AI gets 78% of Q3 revenue from one customer

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

MultiSensor AI Holdings, Inc. (MSAI) reported third-quarter 2026 revenue of $1.505 million, down from $1.574 million a year earlier, and a net loss of $1.949 million versus $1.677 million. For the nine months ended September 30, 2026, revenue rose 16% to $4.814 million and net loss narrowed 27% to $6.880 million. Software revenue increased 81% to $2.293 million for the nine-month period.

Net cash used in operating activities was $4.467 million for nine months, compared with $5.783 million a year earlier; cash and cash equivalents were $20.402 million at September 30, 2026. One customer generated 78% ($1.167 million) of third-quarter revenue. Management said current liquidity sources and projected operating cash flows were expected to provide adequate liquidity for at least the next 12 months.

The largest distribution customer’s rollout across 14 sites was underway. After supplier delays, hardware arrived shortly after quarter-end; installations began in October and were expected to finish in November 2026. After quarter-end, the customer ordered solar monitoring at nine more sites, with installations expected in November. MSAI reported no shares sold under its 2026 at-market agreement, which permits offers of up to $60.0 million in aggregate market value.

3 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 1 point

How the balance works

Positive

  • Moderate pointNine-month revenue increased 16% to $4.814 million.
  • Moderate pointNine-month software revenue grew 81% to $2.293 million.
  • Moderate pointNine-month net loss narrowed 27% to $6.880 million.

Negative

  • Moderate pointThird-quarter net loss widened 16% to $1.949 million.

Filing Explained

As of September 30, 2026, another 4,507,273.85 shares remained potentially issuable under the warrants, beyond the 175,000 already issued.

During the nine months ended September 30, 2026, investors exercised MSAI 2025 warrants for 175,000 shares at $5.98 per share, and the company received $1.0 million. Those issued shares increase the share count and reduce existing holders’ percentage ownership, absent offsetting changes.

At September 30, 2026, warrants for up to 4,507,273.85 additional shares at $5.98 remained outstanding; those shares are not yet issued and would add dilution only if the warrants are exercised.

Revenue, nine months $4.814 million Nine months ended September 30, 2026; up 16% from the prior-year period.
Software revenue, nine months $2.293 million Nine months ended September 30, 2026; up 81% from the prior-year period.
Net loss, nine months $6.880 million Nine months ended September 30, 2026; 27% narrower than the prior-year loss.
Net loss, third quarter $1.949 million Three months ended September 30, 2026; 16% higher than the prior-year quarter’s loss.
Cash used in operating activities $4.467 million Nine months ended September 30, 2026, compared with $5.783 million in the prior-year period.
Cash and cash equivalents $20.402 million As of September 30, 2026.
Customer concentration 78% ($1.167 million) One customer’s share of revenue for the three months ended September 30, 2026.
2026 at-market agreement capacity Up to $60.0 million aggregate market value Common stock sales agreement entered into March 13, 2026; no shares sold through September 30, 2026.
Software as a Service technical
"expansion of our position as a Software as a Service (“SaaS”) provider"
Software as a service (often called SaaS) is software delivered over the internet on a subscription basis, like renting a streaming service instead of buying a DVD. For investors it matters because this model usually creates predictable, recurring revenue, easier scaling to more customers, and clear metrics (subscription growth and churn) that signal business health and future cash flow.
restricted stock units financial
"granted 53,144 restricted stock units subject to time-based vesting conditions"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Performance Stock Units financial
"granted 129,578 Performance Stock Units (“PSUs”)"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
Adjusted EBITDA financial
"We define “Adjusted EBITDA” as EBITDA before share-based compensation expenses"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
Equity Line of Credit financial
"Equity Line of Credit (“ELOC”)"
An equity line of credit is a loan that allows homeowners to borrow money against the value of their property, similar to having a flexible credit card secured by their home. It matters to investors because it provides a way for property owners to access cash for various needs, which can influence real estate markets and overall economic activity. This type of credit offers ongoing borrowing capacity, making it a valuable financial tool for those with significant property equity.
at market issuance sales agreement financial
"entered into an at market issuance sales agreement"
An at market issuance sales agreement is a setup where a company arranges for an agent to sell newly issued shares directly into the public market at the current trading price, usually over time as needed. It matters to investors because it gives the company quick, flexible access to cash without setting a fixed price, but can dilute existing shareholders and affect the stock’s supply and short‑term price behavior—like a shop owner adding extra items to a shelf and selling them at whatever the going price is.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What was MSAI’s revenue for the nine months ended September 30, 2026?

MSAI reported $4.814 million in revenue for the nine months ended September 30, 2026, up 16% from the prior-year period. Software revenue was $2.293 million, an 81% increase.

How much of MSAI’s third-quarter 2026 revenue came from one customer?

One customer accounted for 78%, or $1.167 million, of MSAI’s revenue for the three months ended September 30, 2026.

What are the terms of MSAI’s 2026 at-market sales agreement?

The March 13, 2026 agreement permits offers and sales of common stock with an aggregate market value of up to $60.0 million through Roth Capital Partners, LLC and H.C. Wainwright & Co., LLC, as sales agents or principals. No shares were sold under it during the three or nine months ended September 30, 2026. Net proceeds, if any, are intended for working capital and general corporate purposes.

When were installations expected for MSAI’s 14-site customer rollout?

Installations for the largest distribution customer’s 14-site rollout began in October 2026 and were expected to finish in November 2026. Hardware arrived shortly after quarter-end following supplier delays. After quarter-end, the customer also ordered solar monitoring at nine additional sites, with installations expected in November.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
http://fasb.org/us-gaap/2026#OtherAssetsCurrent0001863990--12-312026Q3false0.025http://fasb.org/us-gaap/2026#OtherAssetsCurrent0.250001863990us-gaap:SalesReturnsAndAllowancesMember2026-09-300001863990us-gaap:SalesReturnsAndAllowancesMember2025-12-310001863990us-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-300001863990us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310001863990us-gaap:AdditionalPaidInCapitalMember2026-04-012026-06-300001863990us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-300001863990us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001863990us-gaap:CommonStockMember2026-07-012026-09-300001863990us-gaap:CommonStockMember2026-01-012026-03-310001863990msai:SalesAgreement2025Member2026-07-012026-09-300001863990us-gaap:CommonStockMember2026-04-012026-06-300001863990msai:SalesAgreement2025Member2026-01-012026-09-300001863990us-gaap:CommonStockMember2025-04-012025-06-300001863990us-gaap:CommonStockMember2025-01-012025-03-3100018639902026-04-132026-04-130001863990us-gaap:RetainedEarningsMember2026-09-300001863990us-gaap:AdditionalPaidInCapitalMember2026-09-300001863990us-gaap:RetainedEarningsMember2026-06-300001863990us-gaap:AdditionalPaidInCapitalMember2026-06-3000018639902026-06-300001863990us-gaap:RetainedEarningsMember2026-03-310001863990us-gaap:AdditionalPaidInCapitalMember2026-03-3100018639902026-03-310001863990us-gaap:RetainedEarningsMember2025-12-310001863990us-gaap:AdditionalPaidInCapitalMember2025-12-310001863990us-gaap:RetainedEarningsMember2025-09-300001863990us-gaap:AdditionalPaidInCapitalMember2025-09-300001863990us-gaap:RetainedEarningsMember2025-06-300001863990us-gaap:AdditionalPaidInCapitalMember2025-06-3000018639902025-06-300001863990us-gaap:RetainedEarningsMember2025-03-310001863990us-gaap:AdditionalPaidInCapitalMember2025-03-3100018639902025-03-310001863990us-gaap:RetainedEarningsMember2024-12-310001863990us-gaap:AdditionalPaidInCapitalMember2024-12-310001863990us-gaap:CommonStockMember2026-09-300001863990us-gaap:CommonStockMember2026-06-300001863990us-gaap:CommonStockMember2026-03-310001863990us-gaap:CommonStockMember2025-12-310001863990us-gaap:CommonStockMember2025-09-300001863990us-gaap:CommonStockMember2025-06-300001863990us-gaap:CommonStockMember2025-03-310001863990us-gaap:CommonStockMember2024-12-310001863990us-gaap:EmployeeStockOptionMember2026-09-300001863990us-gaap:EmployeeStockOptionMember2025-09-300001863990us-gaap:EmployeeStockOptionMember2026-07-012026-09-300001863990us-gaap:EmployeeStockOptionMember2026-01-012026-09-300001863990us-gaap:EmployeeStockOptionMember2025-07-012025-09-300001863990us-gaap:EmployeeStockOptionMember2025-01-012025-09-3000018639902026-06-1200018639902026-06-1100018639902025-06-0400018639902025-06-030001863990us-gaap:PerformanceSharesMember2025-07-012025-09-300001863990us-gaap:PerformanceSharesMember2025-01-012025-09-300001863990us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-03-310001863990us-gaap:TechnologyServiceMember2026-07-012026-09-300001863990us-gaap:ProductMember2026-07-012026-09-300001863990us-gaap:NonUsMember2026-07-012026-09-300001863990msai:AncillaryServicesMember2026-07-012026-09-300001863990country:US2026-07-012026-09-300001863990us-gaap:TechnologyServiceMember2026-01-012026-09-300001863990us-gaap:ProductMember2026-01-012026-09-300001863990us-gaap:NonUsMember2026-01-012026-09-300001863990msai:AncillaryServicesMember2026-01-012026-09-300001863990us-gaap:TechnologyServiceMember2025-07-012025-09-300001863990us-gaap:ProductMember2025-07-012025-09-300001863990us-gaap:NonUsMember2025-07-012025-09-300001863990msai:AncillaryServicesMember2025-07-012025-09-300001863990country:US2025-07-012025-09-300001863990us-gaap:TechnologyServiceMember2025-01-012025-09-300001863990us-gaap:ProductMember2025-01-012025-09-300001863990us-gaap:NonUsMember2025-01-012025-09-300001863990msai:AncillaryServicesMember2025-01-012025-09-300001863990country:US2025-01-012025-09-300001863990us-gaap:SoftwareDevelopmentMember2026-09-300001863990us-gaap:MachineryAndEquipmentMember2026-09-300001863990us-gaap:SoftwareDevelopmentMember2025-12-310001863990us-gaap:MachineryAndEquipmentMember2025-12-310001863990msai:SalesAgreement2025Member2025-07-012025-09-300001863990msai:SalesAgreement2025Member2025-01-012025-09-300001863990msai:EquityLineOfCreditMember2025-01-012025-09-300001863990us-gaap:MajorityShareholderMember2025-01-012025-09-300001863990us-gaap:RetainedEarningsMember2026-07-012026-09-300001863990us-gaap:RetainedEarningsMember2026-04-012026-06-3000018639902026-04-012026-06-300001863990us-gaap:RetainedEarningsMember2026-01-012026-03-3100018639902026-01-012026-03-310001863990us-gaap:RetainedEarningsMember2025-07-012025-09-300001863990us-gaap:RetainedEarningsMember2025-04-012025-06-3000018639902025-04-012025-06-300001863990us-gaap:RetainedEarningsMember2025-01-012025-03-3100018639902025-01-012025-03-310001863990msai:SingleReportableSegmentMember2026-07-012026-09-300001863990msai:SingleReportableSegmentMember2026-01-012026-09-300001863990msai:SingleReportableSegmentMember2025-07-012025-09-300001863990msai:SingleReportableSegmentMember2025-01-012025-09-300001863990msai:CustomerOneMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2026-07-012026-09-300001863990msai:CustomerOneMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-09-300001863990msai:PublicWarrantsMember2026-04-130001863990msai:PrivatePlacementWarrantsMember2026-04-130001863990msai:Warrants2025Member2025-10-240001863990msai:Warrants2025Member2026-09-300001863990msai:Warrants2025Member2026-09-300001863990msai:PublicWarrantsMember2026-09-300001863990msai:PrivatePlacementWarrantsMember2026-09-300001863990msai:FinancingWarrantsMember2026-09-300001863990msai:Warrants2025Member2026-04-130001863990msai:FinancingWarrantsMember2026-04-1300018639902026-04-130001863990msai:Warrants2025Member2026-04-120001863990msai:FinancingWarrantsMember2026-04-1200018639902026-04-120001863990msai:Warrants2025Member2025-10-310001863990msai:FinancingWarrantsMember2023-12-010001863990msai:PublicWarrantsMember2021-10-180001863990msai:PrivatePlacementWarrantsMember2021-10-1800018639902024-12-3100018639902025-09-300001863990us-gaap:RestrictedStockUnitsRSUMembermsai:IncentiveAwardPlan2023Member2026-01-012026-09-300001863990us-gaap:PerformanceSharesMembermsai:IncentiveAwardPlan2023Member2026-01-012026-09-300001863990msai:Warrants2025Member2026-01-012026-09-300001863990msai:PublicWarrantsMember2026-01-012026-09-300001863990msai:PrivatePlacementWarrantsMember2026-01-012026-09-300001863990msai:PerformanceRestrictedStockUnitAwardsMember2026-01-012026-09-300001863990msai:FinancingWarrantsMember2026-01-012026-09-300001863990msai:EarnoutSharesMember2026-01-012026-09-300001863990us-gaap:PerformanceSharesMember2026-07-012026-09-300001863990us-gaap:PerformanceSharesMember2026-01-012026-09-300001863990us-gaap:RestrictedStockUnitsRSUMember2025-07-012025-09-300001863990srt:MinimumMember2026-01-012026-09-300001863990srt:MaximumMember2026-01-012026-09-300001863990us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-3000018639902025-07-012025-09-300001863990msai:Warrants2025Member2026-01-012026-09-300001863990us-gaap:CommonStockMember2025-07-012025-09-300001863990us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-09-300001863990country:US2026-01-012026-09-300001863990us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2026-07-012026-09-300001863990us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-09-3000018639902025-01-012025-09-300001863990msai:EquityLineOfCreditMember2024-04-162024-04-1600018639902026-09-3000018639902025-12-310001863990msai:SalesAgreement2026Member2026-03-130001863990msai:SalesAgreement2025Member2025-03-280001863990msai:EquityLineOfCreditMember2024-04-160001863990us-gaap:RestrictedStockUnitsRSUMember2026-07-012026-09-300001863990us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-09-3000018639902026-07-012026-09-300001863990us-gaap:WarrantMember2026-01-012026-09-300001863990us-gaap:CommonStockMember2026-01-012026-09-3000018639902026-11-090001863990dei:FormerAddressMember2026-01-012026-09-3000018639902026-01-012026-09-30xbrli:sharesiso4217:USDmsai:customerxbrli:puremsai:installmentiso4217:USDxbrli:sharesmsai:segment

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

​

(Mark One)

☒Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2026

or

☐Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from            to

Commission File Number: 001-40916

​

​

MultiSensor AI Holdings, Inc.

(Exact name of registrant as specified in its charter)

​

​

Delaware

(State or other jurisdiction of incorporation or organization)

86-3938682

(I.R.S. Employer Identification No.)

​

11175 Cicero Drive Suite 425

Alpharetta, Georgia, 30022

(Address of principal executive offices and Zip Code)

(866) 861-0788

(Registrant’s telephone number, including area code)

24 Greenway Plaza Suite 1800

Houston, Texas, 77046

(Former name, former address and former fiscal year, if changed since last report)

​

Securities registered pursuant to Section 12(b) of the Act:

​

Title of each class

  ​ ​ ​

Trading Symbol(s)

  ​ ​ ​

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

Warrants to purchase common stock

​

MSAI

MSAIW

​

The Nasdaq Stock Market LLC

The Nasdaq Stock Market LLC

​

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ☒      No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  ☒      No    ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

​

​

​

​

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated filer

☒

Smaller reporting company

☒

​

Emerging growth company

☒

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes  ☐    No  ☒

As of November 9, 2026, there were 2,218,278 shares of the registrant’s common stock outstanding.

i

​

​

​

TABLE OF CONTENTS

​

Page

​

​

FORWARD-LOOKING STATEMENTS

1

PART I – FINANCIAL INFORMATION

2

​

ITEM 1. FINANCIAL STATEMENTS.

2

​

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

15

​

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

23

​

ITEM 4. CONTROLS AND PROCEDURES.

23

PART II – OTHER INFORMATION

25

​

ITEM 1. LEGAL PROCEEDINGS

25

​

ITEM 1A. RISK FACTORS

25

​

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

25

​

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

25

​

ITEM 4. MINE SAFETY DISCLOSURES

25

​

ITEM 5. OTHER INFORMATION

25

​

ITEM 6. EXHIBITS

26

SIGNATURES

28

​

Unless otherwise indicated or the context otherwise requires, references to the “Company,” “we,” “us,” or “our” refer to the business of (i) Infrared Cameras Holdings, Inc., a Delaware corporation (“Legacy ICI”) prior to the consummation of the transactions completed pursuant to that certain business combination agreement, dated as of December 5, 2022, as amended by Amendment No. 1, dated June 27, 2023, and Amendment No. 2, dated September 17, 2023 (the “Business Combination Agreement”, and the transactions contemplated thereby, the “Business Combination”), by and among SportsMap Tech Acquisition Corp., a Delaware corporation (“Legacy SMAP”), ICH Merger Sub Inc., a Delaware corporation and wholly-owned subsidiary of Legacy SMAP (“Merger Sub”) and Legacy ICI, resulting in the merger (the “Merger”) of Merger Sub with and into Legacy ICI, with Legacy ICI surviving as a wholly-owned subsidiary of Legacy SMAP (which subsequently changed its name to MultiSensor AI Holdings, Inc.) and (ii) MultiSensor AI Holdings, Inc. (“MSAI”) and its subsidiaries following the consummation of the Business Combination.

​

​

​

ii

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (the “Quarterly Report”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical facts contained in this Quarterly Report may be forward-looking statements. Words such as “anticipates,” “believes,” “contemplates,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “targets,” or “will” or the negative of these terms or other similar expressions are intended to identify such forward-looking statements. Statements regarding our future results of operations and financial position, business strategy, and plans and objectives of management for future operations, the Company’s expected incurrence of significant expenses and continuing losses in the future, expansion of the Company’s Software as a Service (“SaaS”) capabilities and offerings, the Company’s expectations concerning the earning of subscription revenue, the Company’s expected future research and development costs and expected growth are forward-looking statements.

We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Such forward-looking statements are subject to certain risks, uncertainties and assumptions relating to factors that could cause actual results to differ materially from those anticipated in such statements, including, without limitation, the following:

●continued low income, net losses, negative cash flows from operations and negative net working capital;
●failure to maintain competitive sales prices or reduce costs;
●failure to successfully manage the expansion of our SaaS capabilities and offerings;
●incurrence of substantial research and development costs;
●product recalls, product liability claims and any resultant impact on our reputation;
●certain of the Company’s subscriptions are subject to cancellation without advance notice;
●cost and availability of capital;
●the loss of large customers; and
●the inability to effectively grow our sales, network of distributors, or business prospects.

​

For a more detailed discussion of these and other factors that may affect our business and that could cause the actual results to differ materially from those anticipated in these forward-looking statements, see Part I. Item 1A, “Risk Factors” and Part II. Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (“2025 Annual Report”).

These forward-looking statements speak only as of the date of this Quarterly Report. You should read this Quarterly Report and the documents that we reference in this Quarterly Report and have filed as exhibits to this Quarterly Report completely and with the understanding that our actual future results, levels of activity, performance and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we have no obligation and do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

​

1

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements.

MultiSensor AI Holdings, Inc.

Index to the Condensed Consolidated Financial Statements

  ​ ​ ​

Pages

Condensed Consolidated Balance Sheets (unaudited)

​

3

Condensed Consolidated Statements of Operations (unaudited)

​

4

Condensed Consolidated Statements of Changes in Shareholders’ Equity (unaudited)

​

5

Condensed Consolidated Statements of Cash Flows (unaudited)

​

6

Notes to Condensed Consolidated Financial Statements (unaudited)

​

7

​

​

​

2

MultiSensor AI Holdings, Inc.

Condensed Consolidated Balance Sheets

(unaudited)

(Amounts in thousands of U.S. dollars, except share and per share data)

​

​

​

​

​

​

​

​

​

September 30, 2026

​

December 31, 2025

Assets

​

​

  ​

  ​ ​ ​

​

  ​

Current assets

​

​

  ​

 

​

  ​

Cash and cash equivalents

​

$

20,402

​

$

24,365

Trade accounts receivable, net of allowance for credit losses of $4 and $17, respectively

​

 

1,086

​

 

1,670

Inventories, current

​

 

4,144

​

 

4,020

Other current assets

​

 

1,201

​

 

826

Total current assets

​

$

26,833

​

$

30,881

Property, plant and equipment, net

​

 

3,616

​

 

4,085

Right-of-use assets, net

​

​

104

​

​

—

Inventories, noncurrent

​

 

262

​

 

379

Other noncurrent assets

​

 

205

​

 

129

Total assets

​

$

31,020

​

$

35,474

Liabilities and shareholders’ equity

​

 

​

​

 

​

Current liabilities

​

 

​

​

 

​

Accounts payable

​

$

313

​

$

291

Income taxes payable

​

 

10

​

 

—

Accrued expense

​

 

599

​

 

981

Contract liabilities

​

 

2,462

​

 

1,255

Right-of-use liabilities, current

​

​

72

​

​

—

Other current liabilities

​

 

39

​

 

121

Total current liabilities

​

$

3,495

​

$

2,648

Contract liabilities, noncurrent

​

 

723

​

 

751

Right-of-use liabilities, noncurrent

​

​

32

​

​

—

Warrants

​

​

—

​

​

10

Deferred tax liabilities, net

​

 

32

​

 

33

Total liabilities

​

$

4,282

​

$

3,442

Commitments and contingencies

​

 

​

​

 

  ​

Shareholders’ equity

​

 

​

​

 

  ​

Common stock, $0.0001 par value; 300,000,000 shares authorized as of September 30, 2026 and December 31, 2025, and 2,218,278 and 2,007,613 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively

​

 

—

​

 

—

Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of September 30, 2026 and December 31, 2025, respectively and no shares issued or outstanding as of September 30, 2026 and December 31, 2025, respectively

​

​

—

​

​

—

Additional paid-in capital

​

 

99,957

​

 

98,371

Accumulated deficit

​

 

(73,219)

​

 

(66,339)

Total shareholders’ equity

​

$

26,738

​

$

32,032

Total liabilities and shareholders’ equity

​

$

31,020

​

$

35,474

​

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

​

3

MultiSensor AI Holdings, Inc.

Condensed Consolidated Statements of Operations

(unaudited)

(Amounts in thousands of U.S. dollars, except share and per share data)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended September 30, 

​

Nine Months Ended September 30, 

​

​

2026

​

2025

​

2026

​

2025

Revenue, net

  ​ ​ ​

$

1,505

  ​ ​ ​

$

1,574

  ​ ​ ​

$

4,814

  ​ ​ ​

$

4,163

Cost of goods sold (exclusive of depreciation)

​

​

533

​

​

566

​

​

2,152

​

​

2,126

Operating expenses:

​

 

​

​

 

  ​

​

 

​

​

 

​

Selling, general and administrative

​

 

2,528

​

 

2,164

​

 

8,350

​

 

9,212

Share-based compensation expense

​

​

195

​

​

205

​

​

564

​

​

1,535

Depreciation

​

 

354

​

 

342

​

 

1,066

​

 

952

Loss (gain) on asset disposal

​

​

—

​

​

(9)

​

​

(18)

​

​

(33)

Total operating expenses

​

 

3,077

​

 

2,702

​

​

9,962

​

​

11,666

Operating loss

​

​

(2,105)

​

​

(1,694)

​

​

(7,300)

​

​

(9,629)

Interest expense (income), net

​

 

(141)

​

 

(5)

​

 

(438)

​

 

(20)

Other expense (income), net

​

 

(6)

​

 

(1)

​

 

8

​

 

(181)

Loss before income taxes

​

​

(1,958)

​

​

(1,688)

​

​

(6,870)

​

​

(9,428)

Income tax expense (benefit)

​

​

(9)

​

​

(11)

​

​

10

​

​

7

Net loss

​

$

(1,949)

​

$

(1,677)

​

$

(6,880)

​

$

(9,435)

Weighted-average shares outstanding, basic and diluted

​

 

​

​

 

  ​

​

 

​

​

 

​

Basic

​

 

2,205,648

​

 

862,380

​

 

2,096,483

​

 

838,858

Diluted

​

 

2,205,648

​

 

862,380

​

 

2,096,483

​

 

838,858

Net loss per share, basic and diluted

​

 

​

​

 

​

​

 

​

​

 

​

Basic

​

$

(0.88)

​

$

(1.94)

​

$

(3.28)

​

$

(11.25)

Diluted

​

 

(0.88)

​

 

(1.94)

​

 

(3.28)

​

 

(11.25)

​

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

​

4

MultiSensor AI Holdings, Inc.

Condensed Consolidated Statements of Changes in Shareholders’ Equity

(unaudited)

(Amounts in thousands of U.S. dollars, except share data)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Additional

​

​

​

Total

​

​

Common Stock

​

Paid- In

​

Accumulated

​

Shareholders'

​

  ​ ​ ​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

Capital

  ​ ​ ​

Deficit

  ​ ​ ​

Equity

Balance at January 1, 2025

 

763,151

​

$

—

​

$

66,914

​

$

(54,626)

​

$

12,288

Net loss

 

—

​

 

—

​

 

—

​

 

(4,436)

​

 

(4,436)

Equity-based compensation transactions, net

 

15,996

​

 

—

​

 

407

​

 

—

​

 

407

Issuance of common stock

​

44,793

​

​

—

​

​

4,657

​

​

—

​

​

4,657

Balance at March 31, 2025

 

823,940

​

$

—

​

$

71,978

​

$

(59,062)

​

$

12,916

Net loss

 

—

​

 

—

​

 

—

​

 

(3,322)

​

 

(3,322)

Equity-based compensation transactions, net

 

25,171

​

 

—

​

 

75

​

 

—

​

 

75

Issuance of common stock

​

2,735

​

​

—

​

​

82

​

​

—

​

​

82

Balance at June 30, 2025

 

851,846

​

$

—

​

$

72,135

​

$

(62,384)

​

$

9,751

Net loss

 

—

​

 

—

​

 

—

​

 

(1,677)

​

 

(1,677)

Equity-based compensation transactions, net

 

13,799

​

 

—

​

 

136

​

 

—

​

 

136

Issuance of common stock

​

1,042

​

​

—

​

​

33

​

​

—

​

​

33

Settlement of vendor liability

​

1,099

​

​

—

​

​

36

​

​

—

​

​

36

Balance at September 30, 2025

 

867,786

​

$

—

​

$

72,340

​

$

(64,061)

​

$

8,279

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance at January 1, 2026

 

2,007,613

​

$

—

​

$

98,371

​

$

(66,339)

​

$

32,032

Net loss

 

—

​

 

—

​

 

—

​

 

(2,471)

​

 

(2,471)

Equity-based compensation transactions, net

​

4,680

​

​

—

​

​

158

​

​

—

​

​

158

Balance at March 31, 2026

 

2,012,293

​

$

—

​

$

98,529

​

$

(68,810)

​

$

29,719

Net loss

 

—

​

 

—

​

 

—

​

 

(2,460)

​

 

(2,460)

Equity-based compensation transactions, net

​

18,355

​

​

—

​

​

187

​

​

—

​

​

187

Issuance of common stock

​

175,000

​

​

—

​

​

1,046

​

​

—

​

​

1,046

Balance at June 30, 2026

 

2,205,648

​

$

—

​

$

99,762

​

$

(71,270)

​

$

28,492

Net loss

​

—

​

​

—

​

​

—

​

​

(1,949)

​

​

(1,949)

Equity-based compensation transactions, net

​

12,630

​

​

—

​

​

195

​

​

—

​

​

195

Issuance of common stock

​

—

​

​

—

​

​

—

​

​

—

​

​

—

Balance at September 30, 2026

​

2,218,278

​

$

—

​

$

99,957

​

$

(73,219)

​

$

26,738

​

​

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

​

5

MultiSensor AI Holdings, Inc.

Condensed Consolidated Statements of Cash Flows

(unaudited)

(Amounts in thousands of U.S. dollars)

​

​

​

​

​

​

​

​

​

Nine Months Ended September 30, 

​

​

2026

​

2025

Operating Activities:

  ​ ​ ​

​

  ​

  ​ ​ ​

​

  ​

Net loss

​

$

(6,880)

​

$

(9,435)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

​

 

​

​

 

​

Depreciation

​

 

1,066

​

 

952

Non-cash lease activity

​

 

6

​

 

108

Bad debt expenses (recoveries)

​

​

27

​

​

(1)

Deferred income tax (income) expense

​

 

(1)

​

 

(7)

Share-based compensation

​

 

564

​

 

1,535

Loss (gain) on asset disposal

​

​

(18)

​

​

(33)

Other (income) expenses, net

​

​

(10)

​

​

—

Increase (decrease) in cash resulting from changes in:

​

 

​

​

 

​

Trade accounts receivable

​

 

557

​

 

79

Inventories

​

 

(7)

​

 

51

Other current assets

​

 

(425)

​

 

391

Other noncurrent assets

​

​

(76)

​

​

(55)

Trade accounts payable

​

 

17

​

 

(47)

Income taxes payable

​

 

10

​

 

(57)

Contract liabilities

​

 

1,207

​

 

1,192

Other current liabilities

​

 

(82)

​

 

(114)

Right-of-use liabilities, current

​

 

(6)

​

 

(110)

Accrued expenses

​

 

(388)

​

 

(279)

Contract liabilities, noncurrent

​

​

(28)

​

​

47

Net cash provided by (used in) operating activities

​

$

(4,467)

​

$

(5,783)

Investing Activities:

​

 

​

​

 

​

Capital expenditures

​

 

(588)

​

 

(1,268)

Proceeds from sale of equipment

​

​

20

​

​

24

Net cash provided by (used in) investing activities

​

$

(568)

​

$

(1,244)

Financing Activities:

​

 

​

​

 

​

Proceeds from issuances of common stock

​

​

1,046

​

​

4,773

Tax payments associated with equity-based compensation transactions

​

​

(24)

​

​

(918)

Repayment of Legacy SMAP promissory note

​

​

—

​

​

(172)

Net cash provided by (used in) financing activities

​

$

1,022

​

$

3,683

Net increase/(decrease) in cash, cash equivalents, and restricted cash equivalents

​

 

(4,013)

​

 

(3,344)

Cash, cash equivalents, and restricted cash equivalents beginning of period

​

 

24,465

​

 

4,508

Cash, cash equivalents, and restricted cash equivalents end of the period

​

$

20,452

​

$

1,164

​

​

​

​

​

​

​

Reconciliation of cash, cash equivalents and restricted cash equivalents at end of period:

​

​

​

​

​

​

Cash and cash equivalents

​

$

20,402

​

$

1,064

Restricted cash equivalents included in other current assets

​

​

50

​

​

100

Cash, cash equivalents, and restricted cash equivalents end of the period

​

$

20,452

​

$

1,164

​

​

​

​

​

​

​

Supplemental cash flow information:

​

 

​

​

 

​

Interest paid

​

$

—

​

$

—

Income tax paid, net of refunds received

​

 

10

​

 

110

​

​

​

​

​

​

​

Non-cash investing and financing transactions:

​

​

​

​

​

​

Settlement of vendor liability with share issuance

​

$

—

​

$

36

​

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

​

6

MultiSensor AI Holdings, Inc.

Notes to Condensed Consolidated Financial Statements

(Unaudited; Amounts in thousands of U.S. dollars, except share data)

Note 1 — Organization and Business Operations

MultiSensor AI Holdings, Inc. (“MSAI,” “the Company,” “we,” “us” or “our”) together with its wholly owned subsidiaries build and deploy integrated condition monitoring and early threat detection solutions that connect multiple sensor types through a unified edge-to-cloud software architecture. Our condition intelligence platform integrates multiple sensing modalities such as thermal, visual and acoustic, among others. Customers deploy the MSAI Connect platform to continuously monitor critical assets and identify early degradation patterns (such as elevated operating temperatures) across electrical, mechanical, and environmental systems. This allows teams to intervene early and convert potential failures into planned maintenance before downtime, safety incidents, or operational disruption occur.

We focus on commercial environments where operational continuity is vital and automation intensity is high, including distribution and parcel logistics networks, data centers, and select manufacturing and industrial facilities. We believe our solutions offer a compelling combination of performance, scalability, and cost efficiency relative to traditional inspection and monitoring approaches. Our digital, multi-sensor software platform is designed to support the transition from intermittent, manual asset inspections towards continuous intelligent condition monitoring. By streaming and analyzing radiometric thermal data in combination with other deployed sensor inputs, our MSAI Connect software platform can surface early anomaly signals that may not be visible or detected during periodic inspections. Our system architecture is intentionally modular and extensible, allowing for the integration of additional sensing modalities and analytics capabilities over time.

Note 2 — Reverse Stock Split

On April 13, 2026, we effected a 1-for-40 reverse stock split (the “Reverse Stock Split”) of our common stock, par value $0.0001 per share (the “Common Stock”). As a result of the Reverse Stock Split, our outstanding Common Stock was reduced from 80,491,720 shares to 2,012,293 shares, and proportionate adjustments were made to the number of shares underlying our outstanding equity awards and equity incentive plans, including corresponding adjustments to exercise prices and performance thresholds, as applicable. The total number of authorized shares, the par value per share and other terms of our Common Stock were not affected by the Reverse Stock Split.

Warrants

Pursuant to the terms of the Warrant Agreement, dated October 18, 2021, by and between us and Continental Stock Transfer & Trust Company, and as a result of the Reverse Stock Split, the exercise price of our public warrants to purchase 8,625,000 shares of Common Stock at an exercise price of $11.50 per share (the “Public Warrants”), and private placement warrants to purchase up to 506,250 shares of Common Stock at an exercise price of $11.50 per share (the “Private Placement Warrants” and together with the Public Warrants, the “SPAC Warrants”), each issued in connection with our initial public offering, was adjusted from $11.50 to $460.00. Additionally, the number of shares of Common Stock issuable upon exercise of the Public Warrants and Private Placement Warrants was proportionally reduced to 215,625 shares and 12,657 shares, respectively. Except as provided herein, all other terms and provisions of the SPAC Warrants remain in full force and effect.

Pursuant to the terms of the Subscription Agreement, dated December 1, 2023, by and among us and certain investors signatory thereto, we issued warrants to purchase 340,250 shares of Common Stock at an exercise price of $11.50 per share (the “Financing Warrants”), in connection with our business combination. Under the terms of the Financing Warrants, and as a result of the Reverse Stock Split, the exercise price of the Financing Warrants was adjusted from $11.50 to $460.00 and the number of shares of Common Stock issuable upon exercise of the Financing Warrants was proportionally reduced to 8,507 shares. Except as provided herein, all other terms and provisions of the Financing Warrants remain in full force and effect.

On October 24, 2025, we entered into that certain Securities Purchase Agreement with 325 Capital, LLC (“325 Capital”) and certain other accredited investors signatory thereto (collectively with 325 Capital, the “Investors”), pursuant to which we sold to the Investors shares of Common Stock and warrants to purchase up to 68,459,652 shares of Common Stock (the “2025 Warrants”) (such private placement, the “2025 Private Placement”). Pursuant to the terms of the 2025 Warrants, and as a result of the Reverse Stock Split, the exercise price of the 2025 Warrants was adjusted from $0.409 to $5.98 per share, and the number of shares of Common Stock

7

issuable upon exercise of the 2025 Warrants was proportionately adjusted to 4,682,273.85 shares. Except as provided herein, all other terms and provisions of the 2025 Warrants remain in full force and effect.

All share and per share amounts, including exercise prices and aggregate par values, conversion rates, and conversion prices presented herein that relate to periods prior to the Reverse Stock Split have been adjusted retroactively to reflect the Reverse Stock Split.

Note 3 — Summary of Significant Accounting Policies

Basis of Presentation

The accompanying condensed consolidated financial statements of the Company and its wholly owned subsidiaries are prepared in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”). The interim financial information is unaudited but reflects all normal adjustments that are necessary to provide a fair statement of results for the interim periods presented. This interim information should be read in conjunction with the consolidated financial statements in the 2025 Annual Report. The Condensed Consolidated Balance Sheet as of December 31, 2025 was derived from our audited consolidated financial statements.

Principles of Consolidation

The Company’s condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions have been eliminated.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results may differ materially from those estimates.

Customer Concentration

For the three months ended September 30, 2026, one customer accounted for 78% or $1,167 of total net revenue, which was recorded under the entity’s one operating segment. For the nine months ended September 30, 2026, one customer accounted for 62% or $2,988 of total net revenue, which was recorded under the entity’s one operating segment.

New Accounting Pronouncements

Recently Issued Accounting Standards Not Yet Adopted

In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03 which requires disaggregation of specific expense categories in disclosures within the footnotes to the consolidated financial statements on an annual and interim basis. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Prospective or retrospective application is allowed, and early adoption is permitted. With the exception of expanding disclosures to include more granular income statement expense categories, we do not expect the adoption of ASU 2024-03 to have a material effect on our consolidated financial statements taken as a whole.

​

In September 2025, the FASB issued ASU 2025-06, which amends certain aspects of the accounting for and disclosure of software costs under Accounting Standards Codification 350-40. The new standard is effective for annual reporting periods and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The new standard may be applied prospectively, retrospectively, or via a modified prospective transition method. We are currently evaluating the impact of this new standard on our consolidated financial statements and related disclosures.

8

Note 4 — Revenue

The following tables summarize the Company’s revenue, net disaggregated by type of product and service:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Three Months Ended September 30, 

​

Nine Months Ended September 30, 

​

​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Hardware

​

$

575

​

$

853

​

$

2,418

​

$

2,480

Software

​

 

879

​

 

615

​

 

2,293

​

 

1,266

Services

​

 

51

​

 

106

​

 

103

​

 

417

Total revenue, net

​

$

1,505

​

$

1,574

​

$

4,814

​

$

4,163

​

The Company’s sales policy is not to accept returns of hardware once sold. As a result, there was no sales return reserve as of September 30, 2026 and December 31, 2025.

Contract Liabilities

​

Contract liabilities consist of sales of software subscriptions, where in most cases, the Company receives up-front payment and recognizes revenue over the term of 12-48 months. The Company classifies these contract liabilities as either current or non-current liabilities based on the expected timing of recognition of related revenue. Current contract liabilities were $2,462 and $1,255 and non-current contract liabilities were $723 and $751 as of September 30, 2026 and December 31, 2025, respectively.

Note 5 — Property, Plant and Equipment

The following table summarizes our property, plant and equipment, net:

​

​

​

​

​

​

​

​

​

​

September 30, 

​

December 31, 

​

​

2026

​

2025

Machinery, equipment and demo

​

$

266

​

$

306

Internal-use software

​

 

7,374

​

 

6,800

Property, plant and equipment, gross

​

$

7,640

​

$

7,106

Less: accumulated depreciation

​

 

(4,024)

​

 

(3,021)

Property, plant and equipment, net

​

$

3,616

​

$

4,085

​

Depreciation expense was $354 and $342 for the three months ended September 30, 2026, and 2025, respectively. Depreciation expense was $1,066 and $952 for the nine months ended September 30, 2026, and 2025, respectively.

Note 6 — Other Current Assets

The following table summarizes other current assets:

​

​

​

​

​

​

​

​

​

​

September 30, 

​

December 31, 

​

​

2026

​

2025

Prepaid expenses

​

$

231

​

$

399

Restricted cash equivalents

​

​

50

​

​

100

Prepaid inventory purchases and deposits

  ​ ​ ​

​

611

  ​ ​ ​

​

—

Other receivables

​

 

309

​

 

327

Total other current assets

​

$

1,201

​

$

826

​

During the nine months ended September 30, 2026, the Company renegotiated its contract with the Company’s corporate credit card provider. As a result of this renegotiation, as of September 30, 2026, the Company is required to maintain $50 to collateralize the Company’s corporate credit cards. These funds are held in a money market fund invested in government-backed securities. Although the investment qualifies as a cash equivalent, the funds are not available for general use. As a result, these funds are classified as restricted cash equivalents under the caption Other current assets on the Condensed Consolidated Balance Sheets.

​

9

Note 7 — Inventories

The following table summarizes inventories:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

September 30, 

​

December 31, 

​

​

2026

  ​ ​ ​

2025

Hardware

​

$

3,304

​

$

2,846

Parts and supplies

​

 

840

​

 

1,174

Inventories, current

​

$

4,144

​

$

4,020

Hardware

​

​

32

​

​

32

Parts and supplies

​

 

230

​

 

347

Inventories, noncurrent

​

$

262

​

$

379

Total inventories

​

$

4,406

​

$

4,399

​

​

During the three months ended September 30, 2026, in connection with the Company’s decision to exit its Beaumont manufacturing facility and discontinue certain in-house manufactured products, the Company recorded a charge of $140, included in Cost of goods sold on the Condensed Consolidated Statements of Operations, for the disposal of related inventory components.

​

Note 8 — Accrued Expense

The following table summarizes accrued expense:

​

​

​

​

​

​

​

​

​

​

September 30, 

​

December 31, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Employee compensation and benefits

​

$

402

​

$

683

Professional fees

​

​

30

​

​

181

Other

​

 

167

​

 

117

Total accrued expense

​

$

599

​

$

981

​

​

​

​

​

​

​

Note 9 — Share-Based Compensation

​

Stock Options

​

During the three months ended September 30, 2026, no option awards were granted and no option awards were forfeited. During the nine months ended September 30, 2026, no option awards were granted and 4,628 option awards were forfeited. As of September 30, 2026, 3,006 option awards remained outstanding with a weighted average exercise price of $258.10.

During the three months ended September 30, 2025, no option awards were granted and 1,426 option awards were forfeited. During the nine months ended September 30, 2025, no option awards were granted and 5,626 option awards were forfeited. As of September 30, 2025, 17,828 option awards remained outstanding with a weighted average exercise price of $260.80.

Restricted Stock Units

​

During the three months ended September 30, 2026 and 2025, the Company granted 53,144 and 10,976 restricted stock units subject to time-based vesting conditions (“RSUs”) at a weighted average price of $5.28 and $28.80, respectively. During the nine months ended September 30, 2026 and 2025, the Company granted 59,019 and 55,352 RSUs at a weighted average price of $5.39 and $56.40, respectively. The grant price for all RSU awards was based on the fair value of the Company’s Common Stock on the day immediately prior to the grant.

RSUs generally vest in four equal installments annually on January 1 of each year. RSUs granted in the first quarter of 2025 primarily vested one-fourth of the award value on the date of grant, with the remaining restricted shares vesting in equal installments annually.

The Company recognized share-based compensation expense related to RSUs of $135 and $126 for the three-month periods ended September 30, 2026 and 2025, respectively, and $384 and $1,174 for the nine-month periods ended September 30, 2026 and 2025, respectively under Share-based compensation expense on the Condensed Consolidated Statements of Operations. During the

10

three-month period ended September 30, 2026, 3,000 unvested RSUs were forfeited, resulting in reversal of $13 of share-based compensation expense previously recognized on the Condensed Consolidated Statements of Operations. During the nine-month period ended September 30, 2026, 4,063 unvested RSUs were forfeited, resulting in reversal of $16 of share-based compensation expense previously recognized on the Condensed Consolidated Statements of Operations.

During the three-month periods ended September 30, 2026 and 2025, the Company’s non-employee directors earned $60 and $70, respectively, in compensation for their service on the board, which was paid in the form of RSUs. During the nine-month periods ended September 30, 2026 and 2025, the Company’s non-employee directors earned $180 and $240, respectively, in compensation for their service on the board, which was paid in the form of RSUs. These grants are recognized as share-based compensation expense on the Condensed Consolidated Statements of Operations.

During the nine months ended September 30, 2025, the Company agreed to settle $113 of commissions owed to the Company’s sales force for second quarter performance in RSUs. These grants are recognized as Share-based compensation expense on the Condensed Consolidated Statements of Operations.

Performance Stock Units

​

During the three and nine months ended September 30, 2026 the Company granted 129,578 Performance Stock Units ("PSUs") at a weighted average price of $5.49 to certain executives of the Company with vesting subject to certain revenue achievement levels. No PSUs were issued during the three and nine months ended September 30, 2025. The grant price for all PSUs was based on the fair value of the Company’s Common Stock on the day immediately prior to the grant. Compensation expense for PSUs is recognized on a straight-line basis over the requisite service periods when the achievement of the performance condition is determined to be probable, using management's best estimate. The Company determined it was not probable that it would meet the performance criteria at the end of the performance periods for the outstanding PSUs, therefore no compensation expense was recognized during the three and nine months ended September 30, 2026.

Incentive Award Plan Reserve

​

At our annual shareholders meeting held on June 12, 2026, our shareholders approved an amendment to the Infrared Cameras Holdings, Inc. 2023 Incentive Award Plan (the “2023 Incentive Award Plan”) to increase the number of shares of Common Stock by 500,000, to a total of 661,012 shares of Common Stock issuable pursuant to the 2023 Incentive Award Plan.

At our annual shareholders meeting held on June 4, 2025, our shareholders approved an amendment to the 2023 Incentive Award Plan to increase the number of shares of Common Stock by 85,000, to a total of 161,012 shares of Common Stock issuable pursuant to the 2023 Incentive Award Plan.

​

Note 10 — Shareholders’ Equity

Total authorized capital stock of the Company as of September 30, 2026, is 300,000,000 shares of Common Stock and 10,000,000 shares of preferred stock, par value of $0.0001 per share (“Preferred Stock”). As of September 30, 2026 and December 31, 2025, there were 2,218,278 and 2,007,613 shares of Common Stock issued and outstanding, respectively, and no shares of Preferred Stock issued or outstanding.

11

Equity Line of Credit (“ELOC”)

On April 16, 2024, we entered into that certain common stock purchase agreement (the “Purchase Agreement”) with B. Riley Principal Capital II, LLC (“B. Riley”). Pursuant to the Purchase Agreement, we had the right, but not the obligation, to sell to B. Riley up to $25,000 worth of Common Stock (the “Purchase Shares”) over the term of the Purchase Agreement. In accordance with the Purchase Agreement, on April 16, 2024, we issued 4,296 shares of our Common Stock to B. Riley as consideration for its commitment to purchase the Purchase Shares under the Purchase Agreement (the “Commitment Shares”). Under the terms of the Purchase Agreement, if the aggregate amount of cash proceeds received by B. Riley from the resale of the Commitment Shares was less than $500, then, upon notice by B. Riley, the Company was required to pay the difference between $500 and the aggregate cash proceeds received by B. Riley from its resale. On January 8, 2025, B. Riley notified the Company that it had sold the Commitment Shares, which resolved the liability. Accordingly, $185 was recorded in “Other expense (income), net” in the Condensed Consolidated Statements of Operations for the nine months ended September 30, 2025. Effective February 2, 2026, the Company terminated the Purchase Agreement.

During the three and nine months ended September 30, 2026, the Company did not utilize the ELOC. During the three months ended September 30, 2025, the Company did not utilize the ELOC. During the nine months ended September 30, 2025, the Company sold 44,793 shares of Common Stock under the facility for cash proceeds of $4,657.

At the Market Sales Agreements

On March 13, 2026, the Company entered into an at market issuance sales agreement (the “2026 Sales Agreement”) with Roth Capital Partners, LLC and H.C. Wainwright & Co., LLC, as sales agents or principals (the “Agents”), under which the Company may offer and sell shares of the Company’s Common Stock having an aggregate market value of up to $60,000 from time to time through the Agents. The Agents are entitled to compensation at a fixed commission rate based on the gross sales price of shares sold pursuant to the 2026 Sales Agreement. During the three and nine months ended September 30, 2026, the Company did not sell any shares under the 2026 Sales Agreement.

On March 28, 2025, the Company entered into an at market issuance sales agreement (the “2025 Sales Agreement”) with B. Riley Securities, Inc. (“B. Riley Securities”), as sales agent or principal, pursuant to which the Company could offer and sell shares of its Common Stock having an aggregate offering price of up to $8,625 from time to time through B. Riley Securities. B. Riley Securities was entitled to compensation at a fixed commission rate based on the gross sales price of shares sold pursuant to the 2025 Sales Agreement. The Company terminated the 2025 Sales Agreement effective February 2, 2026. During the three and nine months ended September 30, 2026, the Company did not sell any shares under the 2025 Sales Agreement. During the three and nine months ended September 30, 2025, the Company sold 1,042 and 3,777 shares of Common Stock under the 2025 Sales Agreement for cash proceeds totaling $33 and $116, respectively.

2025 Warrants

In October 2025, the Company completed the 2025 Private Placement pursuant to which it issued shares of Common Stock and the 2025 Warrants to the Investors. The 2025 Warrants have an exercise price of $5.98 per share (as adjusted for the Reverse Stock Split) and expire seven years from issuance. For a complete description of the 2025 Private Placement, see Note 11 to the consolidated financial statements in the 2025 Annual Report.

During the nine months ended September 30, 2026, certain Investors exercised 2025 Warrants for 175,000 shares of Common Stock at an exercise price of $5.98 per share, resulting in proceeds to the Company of $1,046. The proceeds were recorded as an increase to Common Stock and additional paid-in capital. As of September 30, 2026, 2025 Warrants to purchase up to 4,507,273.85 shares of Common Stock (as adjusted for the Reverse Stock Split) remained outstanding.

12

Note 11 — Earnings per Share

The following table summarizes the computation of basic and diluted earnings per share:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Three Months Ended September 30, 

  ​ ​ ​

Nine Months Ended September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Numerator:

 

​

  ​

 

​

  ​

​

​

  ​

 

​

  ​

Basic and diluted net loss attributable to common shareholders

​

$

(1,949)

​

$

(1,677)

​

$

(6,880)

​

$

(9,435)

Denominator:

​

​

​

​

​

​

​

​

​

​

​

​

Weighted average number of shares:

​

 

​

​

 

  ​

​

 

​

​

 

  ​

Basic - common stock

​

​

2,205,648

​

 

862,380

​

 

2,096,483

​

 

838,858

Diluted - common stock

​

 

2,205,648

​

 

862,380

​

 

2,096,483

​

 

838,858

Basic net loss per share attributable to common shareholders

​

$

(0.88)

​

$

(1.94)

​

$

(3.28)

​

$

(11.25)

Diluted net loss per share attributable to common shareholders

​

$

(0.88)

​

$

(1.94)

​

$

(3.28)

​

$

(11.25)

​

The table above does not include the following potential anti-dilutive shares: (i) up to 215,625 shares of Common Stock upon exercise of the Company’s outstanding Public Warrants at an exercise price of $460.00 per share for cash, (ii) up to 12,657 shares of Common Stock issuable upon exercise of the Company’s outstanding Private Placement Warrants at an exercise price of $460.00 per share for cash, (iii) up to 8,507 shares of Common Stock upon exercise of the Financing Warrants at an exercise price of $460.00 per share for cash, (iv) up to 3,006 shares of Common Stock upon the exercise of Company’s options, (v) 80,537 RSU awards and 129,578 PSU awards issued yet unvested under the 2023 Incentive Award Plan as of September 30, 2026, (vi) up to 4,507,273.85 shares of Common Stock issuable upon exercise of the Company’s outstanding 2025 Warrants at an exercise price of $5.98, and (vii) up to 24,400 PSUs committed via employment agreements but unissued as of September 30, 2026.

Note 12 — Related Party Transactions

The Company previously leased its corporate office and currently leases its production facility from a former related party. As of July 29, 2025, the lessor no longer qualified as a related party under the applicable accounting guidance, and payments made after that date did not constitute related party transactions. Total related party cash payments for the leases were $54 for the nine-month period ended September 30, 2025.

​

Note 13 — Commitments and Contingencies

Liabilities for loss contingencies arising from claims, assessments, litigation, fines, and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred.

In the ordinary course of the business, the Company is subject to periodic legal or administrative proceedings. As of September 30, 2026, the Company was not involved in any material claims or legal actions which, in the opinion of management, the ultimate disposition would have a material adverse effect on the Company’s condensed consolidated financial position, results of operations, or liquidity.

​

Note 14 — Income Taxes

The Company has determined that a discrete year-to-date method of reporting would provide more reliable results for the nine months ended September 30, 2026, and September 30, 2025, due to the difficulty in projecting future results. The Company recorded income tax benefit of $9 and $11 for the three months ended September 30, 2026 and 2025, respectively. The Company recorded income tax expense for the nine months ended September 30, 2026 of $10 and income tax expense for the nine months ended September 30, 2025 of $7. The Company maintains a valuation allowance on its deferred tax assets and intends to do so until there is sufficient evidence to support the reversal of all or some portion of this allowance.

For the three months ended September 30, 2026, and 2025, the Company’s effective income tax rates were 0.46% and 0.67%, respectively. For the nine months ended September 30, 2026, and 2025, the Company’s effective income tax rates were (0.15)% and (0.08)%, respectively. The effective tax rates for the three and nine months ended September 30, 2026 and September 30, 2025 were below the U.S. statutory tax rate of 21% primarily due to losses generated by the Company and the Company’s valuation allowance. During 2024 and 2025, the Company determined that it experienced an ownership change as defined under Internal Revenue Code

13

Section 382. The result of the ownership change is subjecting tax attributes to an annual limitation which includes the utilization of the Company’s net operating losses. The Company will continue to monitor ownership changes throughout future periods.

Note 15 — Segments and Geographical Information

The Company has one reportable and operating segment, the manufacturing and distributing of sensor-based systems, software, and services. The Company holds 98% of its assets within the United States. The Company derives revenue primarily in the United States, Canada, European Union member states and the United Kingdom and manages the business activities on a consolidated basis. The following table summarizes revenue based upon the customers’ shipping addresses:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Three Months Ended September 30, 

  ​ ​ ​

Nine Months Ended September 30, 

​

​

2026

  ​ ​ ​

2025

​

2026

  ​ ​ ​

2025

United States

​

$

329

​

$

1,011

​

$

1,314

​

$

3,263

International

​

 

1,176

​

 

563

​

 

3,500

​

 

900

Total revenue, net

​

$

1,505

​

$

1,574

​

$

4,814

​

$

4,163

​

The Company’s chief operating decision maker (“CODM”) is its Chief Executive Officer. The CODM uses consolidated net income to evaluate income generated from segment assets (return on assets) in deciding whether to reinvest profits into the segment or into other parts of the entity, such as for acquisitions. Net income is used to monitor budget versus actual results and to perform competitive analysis through benchmarking to competitors. The competitive analysis along with the monitoring of budgeted versus actual results are used in assessing performance of the segment and in establishing management’s compensation.

The table below summarizes the significant expense categories regularly reviewed by the CODM for the three- and nine-month periods ended September 30, 2026, and 2025:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended September 30, 

​

Nine Months Ended September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Revenue, net

​

$

1,505

 

$

1,574

​

$

4,814

 

$

4,163

Cost of goods sold (exclusive of depreciation)

​

 

533

 

​

566

​

 

2,152

 

​

2,126

Operating expenses:

​

 

​

 

​

​

​

 

​

 

​

​

Selling, general and administrative

​

 

2,528

​

​

2,164

​

 

8,350

​

​

9,212

Employee compensation and benefits

​

 

1,535

 

​

1,137

​

 

4,592

 

​

4,336

Professional Fees

​

 

333

 

​

418

​

 

1,723

 

​

2,892

Other selling, general and administrative

​

 

660

 

​

609

​

 

2,035

 

​

1,984

Other operating expenses

​

 

549

 

​

538

​

 

1,612

 

​

2,454

Non-operating (income) expenses, net

​

 

(147)

 

​

(6)

​

 

(430)

 

​

(201)

Income tax expense (benefit)

​

 

(9)

 

​

(11)

​

 

10

 

​

7

Net loss

​

$

(1,949)

 

$

(1,677)

​

$

(6,880)

 

$

(9,435)

​

See the condensed consolidated financial statements for other financial information regarding the Company’s operating segment.

​

14

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of our financial condition and results of operations provides information that our management believes is relevant to an assessment and understanding of our consolidated results of operations and financial condition. This discussion should be read in conjunction with our audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and in our unaudited condensed consolidated financial statements and notes thereto, included elsewhere in this Quarterly Report (collectively, the “consolidated financial statements”). References to “MSAI,” the “Company,” “we,” “us,” or “our” refer to MultiSensor AI Holdings, Inc.

This Quarterly Report includes forward-looking statements based on the Company’s current assumptions, expectations and projections about future events that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under “Risk Factors” or in other parts of this Quarterly Report. For more information on these and other factors, see “Forward-Looking Statements” herein.

Overview

The Company and its wholly owned subsidiaries build and deploy integrated condition monitoring and early threat detection solutions that connect multiple sensor types through a unified edge-to-cloud software architecture. Our condition intelligence platform integrates multiple sensing modalities such as thermal, visual and acoustic, among others. Customers deploy the MSAI Connect platform to continuously monitor critical assets and identify early degradation patterns (such as elevated operating temperatures) across electrical, mechanical, and environmental systems. This allows customers to intervene early and convert potential failures into planned maintenance before downtime, safety incidents, or operational disruption occur. Unlike traditional inspection or single-sensor monitoring solutions, MSAI combines multiple sensing technologies into a unified software platform that provides a single operational view of asset health. Our strategy is to become the software platform that connects multiple sensing technologies into a unified operational intelligence layer across critical infrastructure.

We are pursuing expansion of our position as a Software as a Service (“SaaS”) provider in predictive maintenance and believe there are significant opportunities to increase recurring revenue from our solutions. We focus on commercial environments where operational continuity is vital and automation intensity is high, including distribution and parcel logistics networks, data centers, and select manufacturing and industrial facilities. We believe our solutions offer a compelling combination of performance, scalability, and cost efficiency relative to traditional inspection and monitoring approaches. Our digital, multi-sensor software platform is designed to support the transition from intermittent, manual asset inspections towards continuous intelligent condition monitoring. By streaming and analyzing radiometric thermal data in combination with other deployed sensor inputs, our MSAI Connect platform can surface early anomaly signals that may not be visible or detected during periodic inspections. Our system architecture is intentionally modular and extensible, allowing for the integration of additional sensing modalities and analytics capabilities over time. While our current commercial deployments are centered primarily on thermal-based monitoring enhanced by software-driven analytics and expert review, we believe MSAI Connect’s multi-sensor foundation positions us to expand into broader predictive and prescriptive use cases.

Through collaboration with several blue-chip multinational customers during development and deployment, we have validated high-value, mission-critical use cases across our target markets: distribution and logistics, manufacturing and data centers. These engagements have informed our product evolution and reinforced our belief that integrated, AI-enabled multi-sensor monitoring represents a structural shift in how industrial reliability and asset protection are managed.

We continue to expand the capabilities of our MSAI Connect platform. In September 2026, we launched Solar Reflection Analysis within our Solar Performance Monitoring solution. The capability evaluates thermal events in the context of the sun's position and time of day to indicate whether an event is likely caused by sun reflection or should be investigated as a potential electrical or mechanical fault, helping customers reduce false alerts and focus maintenance resources on genuine risks. This follows the expansion of our vibration coverage in June 2026 through our collaboration with Broadsens, which allows customers to evaluate thermal and vibration data for the same asset within a single workflow.

During the third quarter of 2026, we also continued to build our presence as a thought leader in reliability and maintenance through the release of our Reliability Maturity Research Series, including a webinar presented with Reliabilityweb, and The Uptime Economy: 2026 Report, a survey of reliability, maintenance and operations leaders in e-commerce distribution and logistics. We believe these initiatives strengthen our engagement with reliability and maintenance decision-makers in our target markets and support awareness of the value of continuous condition monitoring.

15

In the distribution and logistics market, we believe our solutions deliver meaningful operational value by helping customers minimize unplanned downtime, lower labor and maintenance costs, and improve facility throughput. Our customer relationships in this market typically begin with an initial deployment and expand as customers validate results across their operations. We saw continued progress in this pattern during the third quarter of 2026. With our largest distribution customer, the first rollout of our solution across 14 sites in North America is underway. Due to supplier delays, hardware for the rollout was delivered shortly after quarter end, and installations commenced in October 2026 with an expected completion date in November 2026. Subsequent to quarter end, this customer also issued purchase orders to extend our solar monitoring solution to nine additional sites, with installations expected in November 2026. Similarly, Manchester Airports Group issued purchase orders subsequent to quarter end to expand our deployment at Manchester Airport by adding an additional screening area and building on the initial deployment completed earlier in 2026. We also continued to add new customers that we believe have similar expansion potential, including an initial proof of value deployment during the third quarter of 2026 at a national distribution center of a leading Australian supply chain and logistics provider, which expands our presence to the Asia-Pacific region.

During the third quarter of 2026, we continued to advance our data center pilot with a leading global cloud infrastructure provider, which focuses on continuous monitoring of high-voltage electrical switch rooms and mechanical pump rooms. Based on the results of the pilot to date, we have submitted a proposal to expand our deployment across additional electrical infrastructure at the pilot facility, and we are in discussions regarding potential deployment at additional facilities. Our second pilot, at a data center operated by an industrial manufacturer, has been completed, and we continue to engage with this customer regarding potential applications of our solutions across its operations.

In the manufacturing market, our go-to-market strategy is centered on delivering early threat detection and operational reliability for the critical electrical and mechanical assets that support production. We continue to work with two of the “Big 3” U.S. automakers, including on programs focused on lithium-ion battery pack monitoring. We believe the addition of vibration monitoring announced in the second quarter of 2026 strengthens our platform's capabilities to monitor motors, pumps and other rotating equipment, which broadens the range of production assets and manufacturing environments our solutions can address.

Recent Developments

Reverse Stock Split

On April 13, 2026, we effected a 1-for-40 reverse stock split (the “Reverse Stock Split”) of our common stock, par value $0.0001 per share (the “Common Stock”). As a result of the Reverse Stock Split, our outstanding Common Stock was reduced from 80,491,720 shares to 2,012,293 shares, and proportionate adjustments were made to the number of shares underlying our outstanding equity awards and equity incentive plans, including corresponding adjustments to exercise prices and performance thresholds, as applicable. The total number of authorized shares, the par value per share and other terms of our Common Stock were not affected by the Reverse Stock Split.

Warrants

Pursuant to the terms of the Warrant Agreement, dated October 18, 2021, by and between the Company and Continental Stock Transfer & Trust Company, and as a result of the Reverse Stock Split, the exercise price of the Company’s public warrants to purchase 8,625,000 shares of Common Stock at an exercise price of $11.50 per share (the “Public Warrants”), and private placement warrants to purchase up to 506,250 shares of Common Stock at an exercise price of $11.50 per share (the “Private Placement Warrants” and together with the Public Warrants, the “SPAC Warrants”), each issued in connection with our initial public offering, was adjusted from $11.50 to $460.00. Additionally, the number of shares of Common Stock issuable upon exercise of the Public Warrants and Private Placement Warrants was proportionally reduced to 215,625 shares and 12,657 shares, respectively. Except as provided herein, all other terms and provisions of the SPAC Warrants remain in full force and effect.

Pursuant to the terms of the Subscription Agreement, dated December 1, 2023, by and among the Company and certain investors signatory thereto, and as a result of the Reverse Stock Split, the exercise price of the Company’s warrants to purchase 340,250 shares of Common Stock at an exercise price of $11.50 per share (the “Financing Warrants”), issued in connection with our business combination, was adjusted from $11.50 to $460.00. Additionally, the number of shares of Common Stock issuable upon exercise of the Financing Warrants was proportionally reduced to 8,507 shares. Except as provided herein, all other terms and provisions of the Financing Warrants remain in full force and effect.

16

On October 24, 2025, we entered into a Securities Purchase Agreement (the “2025 Purchase Agreement”) with 325 Capital, LLC (“325 Capital”) and certain other accredited investors signatory thereto (collectively with 325 Capital, the “Investors”), pursuant to which we sold to the Investors shares of Common Stock and warrants to purchase up to 68,459,652 shares of Common Stock (the “2025 Warrants”). Pursuant to the terms of the 2025 Warrants, and as a result of the Reverse Stock Split, the exercise price of the 2025 Warrants was adjusted from $0.409 to $5.98 per share, and the number of shares of Common Stock issuable upon exercise of the 2025 Warrants was proportionately adjusted to 4,682,273.85 shares. Except as provided herein, all other terms and provisions of the 2025 Warrants remain in full force and effect. During the nine months ended September 30, 2026, certain Investors exercised 2025 Warrants for 175,000 shares of Common Stock at $5.98 per share, resulting in proceeds of $1.0 million.

Results of Operations

Three months ended September 30, 2026 compared to three months ended September 30, 2025

The following table presents summary results of operations for the periods indicated in thousands:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Three Months Ended September 30, 

  ​ ​ ​

Amount

  ​ ​ ​

%

 

​

​

2026

  ​ ​ ​

2025

​

Change

​

 Change

​

Revenue, net

​

$

1,505

​

$

1,574

​

$

(69)

 

(4)

%

Cost of goods sold (exclusive of depreciation)

​

​

533

​

​

566

​

​

(33)

 

(6)

%

Operating expenses:

​

​

​

​

​

​

​

​

​

 

  ​

​

Selling, general and administrative

​

​

2,528

​

​

2,164

​

​

364

 

17

%

Share-based compensation expense

​

​

195

​

​

205

​

​

(10)

​

(5)

%

Depreciation

​

​

354

​

​

342

​

​

12

 

4

%

Loss (gain) on asset disposal

​

​

—

​

​

(9)

​

​

9

​

(100)

%

Total operating expenses

​

​

3,077

​

​

2,702

​

​

375

 

14

%

Operating loss

​

​

(2,105)

​

​

(1,694)

​

​

(411)

 

24

%

Interest expense (income), net

​

​

(141)

​

​

(5)

​

​

(136)

 

2,720

%

Other expense (income), net

​

​

(6)

​

​

(1)

​

​

(5)

 

500

%

Loss before income taxes

​

​

(1,958)

​

​

(1,688)

​

​

(270)

 

16

%

Income tax expense (benefit)

​

​

(9)

​

​

(11)

​

​

2

 

(18)

%

Net loss

​

$

(1,949)

​

$

(1,677)

​

$

(272)

 

16

%

​

Revenue: Revenue for the three months ended September 30, 2026 was $1.5 million, compared to $1.6 million for the three months ended September 30, 2025. Revenue from each of our products and services are summarized below for the three months ended September 30, 2026 and 2025.

​

​

​

​

​

​

​

​

  ​ ​ ​

Three Months Ended September 30, 

​

​

2026

  ​ ​ ​

2025

Hardware

​

$

575

​

$

853

Software

​

 

879

​

 

615

Services

​

 

51

​

 

106

Total revenue

​

$

1,505

​

$

1,574

​

The decrease in revenue was primarily attributable to a decrease in hardware revenue of $0.3 million, or 33%, and a decrease in services revenue of $0.1 million, or 52%, primarily related to the discontinuation of inspection and training services in August 2025. These decreases were partially offset by an increase in software revenue of $0.3 million, or 43%, in line with our strategic initiative of transitioning away from being a hardware provider to being a solutions provider by focusing on growing our SaaS business.

Cost of Goods Sold: Cost of goods sold for the three months ended September 30, 2026 was $0.5 million, compared to $0.6 million for the three months ended September 30, 2025. The decrease in cost of goods sold was primarily attributable to a reduction in hardware sold, partially offset by a $0.1 million charge incurred in the third quarter of 2026 related to the disposal of certain components from discontinued product lines.

Selling, General and Administrative Expense: Selling, general and administrative expense for the three months ended September 30, 2026 was $2.5 million, compared to $2.2 million for the three months ended September 30, 2025. The increase in selling,

17

general and administrative expenses was primarily driven by a $0.4 million increase in payroll expenses, including bonus, partially offset by a $0.1 million decrease in professional fees due to the Company’s continued strategic cost optimization initiatives.

Share-Based Compensation Expense: Share-based compensation expense for the three months ended September 30, 2026 was $0.2 million, compared to $0.2 million for the three months ended September 30, 2025. The slight decrease in share-based compensation expense was primarily related to forfeitures of unvested awards previously granted predominantly as a result of the reduction in workforce, which occurred in July 2025.

Depreciation: Depreciation expense was $0.4 million for the three months ended September 30, 2026, compared to $0.3 million for the three months ended September 30, 2025. The increase in depreciation expense was primarily driven by additions, predominantly in the internal-use software category, associated with our development of MSAI Connect, partially offset by lower depreciation expense related to machinery, equipment, and demo assets due to disposals and sales completed during fiscal year 2025.

Interest expense (income), net: Interest income was $0.1 million for the three months ended September 30, 2026, compared to insignificant interest income for the three months ended September 30, 2025. The increase in interest income was primarily due to higher average cash balances invested in interest-bearing accounts.

​

Nine months ended September 30, 2026 compared to nine months ended September 30, 2025

The following table presents summary results of operations for the periods indicated in thousands:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Nine Months Ended September 30, 

  ​ ​ ​

Amount

  ​ ​ ​

%

 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

​

Change

​

 Change

​

Revenue, net

​

$

4,814

​

$

4,163

​

$

651

 

16

%

Cost of goods sold (exclusive of depreciation)

​

​

2,152

​

​

2,126

​

​

26

 

1

%

Operating expenses:

​

​

​

​

​

​

​

​

​

 

  ​

​

Selling, general and administrative

​

​

8,350

​

​

9,212

​

​

(862)

 

(9)

%

Share-based compensation expense

​

​

564

​

​

1,535

​

​

(971)

​

(63)

%

Depreciation

​

​

1,066

​

​

952

​

​

114

 

12

%

Loss (gain) on asset disposal

​

​

(18)

​

​

(33)

​

​

15

​

(45)

%

Total operating expenses

​

​

9,962

​

​

11,666

​

​

(1,704)

 

(15)

%

Operating loss

​

​

(7,300)

​

​

(9,629)

​

​

2,329

 

(24)

%

Interest expense (income), net

​

​

(438)

​

​

(20)

​

​

(418)

 

2,090

%

Other expense (income), net

​

​

8

​

​

(181)

​

​

189

 

(104)

%

Loss before income taxes

​

​

(6,870)

​

​

(9,428)

​

​

2,558

 

(27)

%

Income tax expense (benefit)

​

​

10

​

​

7

​

​

3

 

43

%

Net loss

​

$

(6,880)

​

$

(9,435)

​

$

2,555

 

(27)

%

​

Revenue: Revenue for the nine months ended September 30, 2026 was $4.8 million, compared to $4.2 million for the nine months ended September 30, 2025. Revenue from each of our products and services are summarized below for the nine months ended September 30, 2026 and 2025.

​

​

​

​

​

​

​

​

  ​ ​ ​

Nine Months Ended September 30, 

​

​

2026

  ​ ​ ​

2025

Hardware

​

$

2,418

​

$

2,480

Software

​

 

2,293

​

 

1,266

Services

​

 

103

​

 

417

Total revenue

​

$

4,814

​

$

4,163

​

The increase in revenue was primarily attributable to growth in software revenue, in line with our strategic initiative of transitioning away from being a hardware provider to being a solutions provider. Software revenue grew 81% to $2.3 million as the Company continues to focus on growing our SaaS business. This increase in revenue was partially offset by a decrease in services revenue of $0.3 million, or 75%, primarily related to the discontinuation of inspection and training services in August 2025.

18

Cost of Goods Sold: Cost of goods sold for the nine months ended September 30, 2026 was $2.2 million, compared to $2.1 million for the nine months ended September 30, 2025. Cost of goods sold remained relatively consistent despite higher revenue, primarily due to a shift in revenue mix toward software, partially offset by a $0.1 million charge incurred in the third quarter of 2026 related to the disposal of certain components from discontinued product lines.

Selling, General and Administrative Expense: Selling, general and administrative expense for the nine months ended September 30, 2026 was $8.4 million, compared to $9.2 million for the nine months ended September 30, 2025. The decrease in selling, general and administrative expenses was primarily driven by a $1.2 million decrease in professional fees due to the Company’s continued strategic cost optimization initiatives, partially offset by a $0.3 million increase in payroll expenses, including bonus.

Share-Based Compensation Expense: Share-based compensation expense for the nine months ended September 30, 2026 was $0.6 million, compared to $1.5 million for the nine months ended September 30, 2025. The decrease in share-based compensation expense was primarily attributable to restricted stock units granted during the first quarter of 2025, which included a provision for immediate vesting of 25% of the total award, resulting in higher expense recognized in the prior-year period and forfeitures of unvested awards previously granted predominantly as a result of the reduction in our workforce which occurred in July 2025.

Depreciation: Depreciation expense was $1.1 million for the nine months ended September 30, 2026, compared to $1.0 million for the nine months ended September 30, 2025. The increase in depreciation expense was primarily driven by additions, predominantly in the internal-use software category, associated with our development of MSAI Connect, partially offset by lower depreciation expense related to machinery, equipment, and demo assets due to disposals and sales completed during fiscal year 2025.

Interest expense (income), net: Interest income was $0.4 million for the nine months ended September 30, 2026, compared to insignificant interest income for the nine months ended September 30, 2025. The increase in interest income was primarily due to higher average cash balances invested in interest-bearing accounts.

​

Other expense (income), net: Other expense (income), net for the nine months ended September 30, 2026 was insignificant compared to $0.2 million of income for the nine months ended September 30, 2025 primarily due to the resolution of the ELOC make-whole obligation, as notified by B. Riley on January 8, 2025, which resulted in a one-time benefit recorded in the prior-year period.

Non-GAAP Financial Measures

EBITDA and Adjusted EBITDA

Earnings before interest, taxes, depreciation and amortization (“EBITDA”) and Adjusted EBITDA are supplemental non-GAAP financial measures used by management. We define EBITDA as net income (loss) before (i) interest expense (net interest income), (ii) depreciation and (iii) taxes. We define “Adjusted EBITDA” as EBITDA before share-based compensation expenses, change in fair value of convertible notes and warrant liabilities, loss on financing transaction, other expense (income) and loss (gain) on disposal of assets, as each are applicable to the periods presented.

We believe EBITDA and Adjusted EBITDA are useful performance measures because they facilitate comparison of our results of operations from period to period without regard to our financing methods or capital structure or other items that impact comparability of financial results from period to period such as fluctuations in interest expense or effective tax rates, levels of depreciation, non-cash charges such as share based compensation expenses or unusual items that are not considered an indicator of ongoing performance of our operations. In addition, we believe that such non-GAAP financial measures are used by analysts and others in the investment community to analyze our historical results and to provide estimates of future performance. EBITDA and Adjusted EBITDA should not be considered as alternatives to, or more meaningful than, net income (loss) or any other measure as determined in accordance with GAAP. Our computations of EBITDA and Adjusted EBITDA may not be comparable to EBITDA or Adjusted EBITDA of other companies. We present EBITDA and Adjusted EBITDA because we believe they provide useful information regarding the factors and trends affecting our business.

We believe EBITDA and Adjusted EBITDA, when viewed in a reconciliation to respective GAAP measures, provide an additional way of viewing the Company’s results of operations and factors and trends affecting the Company’s business. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the respective financial results presented in accordance with GAAP. The following tables present a reconciliation of EBITDA and Adjusted EBITDA to the GAAP financial measure of net income (loss) (unaudited) for each of the periods indicated, in thousands:

19

EBITDA and Adjusted EBITDA

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Three Months Ended September 30, 

 

Nine Months Ended September 30, 

Adjusted EBITDA

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Net loss

​

$

(1,949)

​

$

(1,677)

​

$

(6,880)

​

$

(9,435)

Interest expense (income), net

​

​

(141)

​

​

(5)

​

​

(438)

​

​

(20)

Income tax expense (benefit)

​

​

(9)

​

​

(11)

​

​

10

​

​

7

Depreciation

​

​

354

​

​

342

​

​

1,066

​

​

952

EBITDA

​

$

(1,745)

​

$

(1,351)

​

$

(6,242)

​

$

(8,496)

Share-based compensation expense

​

 

195

​

 

205

​

 

564

​

 

1,535

Other expense (income), net

​

 

(6)

​

 

(1)

​

 

8

​

 

(181)

Loss (gain) on asset disposal

​

​

—

​

​

(9)

​

​

(18)

​

​

(33)

Adjusted EBITDA

​

$

(1,556)

​

$

(1,156)

​

$

(5,688)

​

$

(7,175)

​

Liquidity and Capital Resources

We incurred losses for the three and nine months ended September 30, 2026. We have historically funded our operations with internally generated cash flows, equity financings, debt, convertible notes, and promissory notes with shareholders and related parties. As of September 30, 2026, we had $20.4 million of cash and cash equivalents. We expect that our current sources of liquidity, together with our projection of cash flows from operating activities, will provide us with adequate liquidity for at least the next 12 months.

We may require additional capital in order to execute on our business plan and may require capital to fund our operations or to respond to technological advancements, competitive dynamics, technologies, customer demands, business opportunities, challenges, acquisitions, or unforeseen circumstances, and we may determine to raise capital through equity or debt financings or enter into credit facilities for other reasons. In order to maintain our anticipated growth trajectory and to further business relationships with current or potential customers or partners, or for other reasons, we may issue equity or equity-linked securities to such current or potential customers or partners. We may not be able to timely secure additional debt or equity financing on favorable terms, or at all, as these plans are subject to market conditions and are not within our control. There is no assurance that we will be successful in implementing our plans. If we raise additional funds through the issuance of equity or convertible debt or other equity-linked securities, or if we issue equity or equity-linked securities to current or potential customers to further business relationships, our existing shareholders could experience significant dilution. Any debt financing obtained by us in the future could involve restrictive covenants relating to our capital raising and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. If we are unable to obtain adequate financing or financing on terms satisfactory to us, when we require it, our ability to continue to grow or support our business and to respond to business challenges could be significantly limited and our business could be materially and adversely affected.

Equity Line of Credit (“ELOC”)

​

On April 16, 2024, we entered into a common stock purchase agreement (the “Purchase Agreement”) with B. Riley Principal Capital II, LLC (“B. Riley”). Pursuant to the Purchase Agreement, we had the right, but not the obligation, to sell to B. Riley up to $25.0 million worth of the Company’s Common Stock (such shares when issued, the “Purchase Shares”) over the term of the Purchase Agreement, beginning only after certain conditions set forth in the Purchase Agreement have been satisfied, including that an amendment to the registration statement registering the Purchase Shares for resale shall have been declared effective under the Securities Act of 1933, as amended. During the three and nine months ended September 30, 2026, the Company did not utilize the ELOC to sell shares and terminated the Purchase Agreement effective February 2, 2026.

During the three months ended September 30, 2025, the Company did not utilize the ELOC to sell shares. During the nine months ended September 30, 2025, the Company utilized the ELOC to sell a total of 44,793 shares of Common Stock for cash proceeds totaling $4.7 million, all of which occurred during the first quarter.

At the Market Sales Agreements

On March 13, 2026, the Company entered into an at market sales agreement (the “2026 Sales Agreement”) with Roth Capital Partners, LLC and H.C. Wainwright & Co., LLC, as sales agents or principals, under which the Company may offer and sell shares of its Common Stock having an aggregate market value of up to $60.0 million from time to time. During the three and nine months ended

20

September 30, 2026, the Company did not sell any shares under the 2026 Sales Agreement. We intend to use the net proceeds from sales of Common Stock under the 2026 Sales Agreement, if any, for working capital and general corporate purposes.

On March 28, 2025, the Company entered into an at market issuance sales agreement (the “2025 Sales Agreement”) with B. Riley Securities, Inc., as sales agent or principal, having an aggregate market value of up to $8.6 million. The Company terminated the 2025 Sales Agreement effective February 2, 2026, and did not sell any shares under the 2025 Sales Agreement during the three or nine months ended September 30, 2026. During the three and nine months ended September 30, 2025, the Company sold 1,042 and 3,777 shares of Common Stock under the 2025 Sales Agreement for cash proceeds totaling less than $0.1 million and $0.1 million, respectively.

2025 Private Placement

​

On October 24, 2025, the Company entered into the 2025 Purchase Agreement with the Investors, pursuant to which it agreed to sell to the Investors (i) 855,745 shares of Common Stock at a purchase price of $16.36 per share and (ii) the 2025 Warrants (collectively, the “2025 Private Placement”), with an exercise price of $5.98 per share, for an aggregate purchase price of $14 million before deducting placement agent fees and offering expenses. 325 Capital and its affiliates beneficially own more than 5.0% of the outstanding Common Stock. In addition, Daniel M. Friedberg, who is a Managing Member of 325 Capital, serves on the Company’s board of directors.

The 2025 Purchase Agreement and the 2025 Warrants provide that each Investor’s beneficial ownership of Common Stock, including after taking into account the full exercise of such Investor’s 2025 Warrant, shall in no event exceed 49.5% of the issued and outstanding Common Stock (the “Maximum Ownership Limitation”). In the event that an Investor’s 2025 Warrant is not exercisable for shares of Common Stock due to the beneficial ownership of such Investor exceeding the Maximum Ownership Limitation, the applicable 2025 Warrant will be exercisable for shares of the Company’s Series A Convertible Preferred Stock, par value $0.0001 per share, that are convertible into an equivalent number of shares of Common Stock for which the 2025 Warrant is exercisable. The 2025 Warrants will expire seven years from the date of issuance.

At the initial closing of the 2025 Private Placement on October 30, 2025, the Company issued to the Investors 174,272 shares of Common Stock, and 2025 Warrants to purchase up to 953,543.13 shares of Common Stock (as adjusted for the Reverse Stock Split), for gross proceeds of $2.85 million before deducting placement agent fees and offering expenses.

On December 23, 2025, the final closing occurred and the Company issued 681,474 shares of Common Stock and 2025 Warrants to purchase up to 3,728,730.72 shares of Common Stock (as adjusted for the Reverse Stock Split) to the Investors for gross proceeds of $11.15 million before deducting placement agent fees and offering expenses.

During the nine months ended September 30, 2026, certain Investors exercised 2025 Warrants for 175,000 shares of Common Stock at an exercise price of $5.98 per share, resulting in proceeds to the Company of $1.0 million. As of September 30, 2026, 2025 Warrants to purchase up to 4,507,273.85 shares of Common Stock (as adjusted for the Reverse Stock Split) remained outstanding.

2025 Registered Direct Offering

​

On November 4, 2025, the Company entered into a common stock purchase agreement with a single institutional investor, pursuant to which the Company agreed to issue and sell (i) 114,875 shares (the “2025 Registered Direct Shares”) of the Company’s Common Stock and (ii) pre-funded warrants (the “2025 Pre-Funded Warrants”) to purchase up to 152,500 shares of Common Stock (the “2025 Pre-Funded Warrant Shares”) in a registered direct offering (the “2025 Registered Direct Offering”). The 2025 Registered Direct Shares, 2025 Pre-Funded Warrants and 2025 Pre-Funded Warrant Shares are registered pursuant to an effective shelf registration statement on Form S-3 (File No. 333-284437), and a base prospectus and prospectus supplement relating to the 2025 Registered Direct Offering, in each case filed with the SEC. The offering price was $54.00 per share of Common Stock and $53.9999 per 2025 Pre-Funded Warrant, which is the price of each share of Common Stock sold in the 2025 Registered Direct Offering, minus the $0.0001 exercise price per 2025 Pre-Funded Warrant.

The 2025 Registered Direct Offering closed on November 5, 2025, and resulted in gross proceeds to the Company of approximately $14.4 million, before deducting advisory fees and offering expenses payable by the Company. Following the delivery of exercise notices to the Company on November 5, 2025 and November 6, 2025, the 2025 Pre-Funded Warrants were exercised in full.

21

Cash Flows

Nine months ended September 30, 2026, compared to nine months ended September 30, 2025

The following table summarizes our cash flows for the periods indicated, in thousands:

​

​

​

​

​

​

​

​

  ​ ​ ​

Nine Months Ended September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Net cash provided by (used in) operating activities

​

$

(4,467)

​

$

(5,783)

Net cash provided by (used in) investing activities

​

 

(568)

​

 

(1,244)

Net cash provided by (used in) financing activities

​

 

1,022

​

 

3,683

Net increase/(decrease) in cash, cash equivalents, and restricted cash equivalents

​

$

(4,013)

​

$

(3,344)

​

Operating Activities

Net cash used in operating activities was $4.5 million for the nine months ended September 30, 2026, a decrease of $1.3 million as compared to $5.8 million of net cash used in operating activities for the nine months ended September 30, 2025. The decrease in net cash used in operating activities was primarily driven by a $2.3 million decrease in operating loss, from $9.6 million for the nine months ended September 30, 2025 to $7.3 million for the nine months ended September 30, 2026, partially offset by lower non-cash share-based compensation expense and changes in working capital, including a $0.6 million increase in prepaid inventory purchases and deposits.

Investing Activities

Net cash used in investing activities was $0.6 million for the nine months ended September 30, 2026, a decrease of $0.7 million as compared to $1.2 million of net cash used in investing activities for the nine months ended September 30, 2025. The decrease was primarily related to a decrease in cash paid for capital expenditures.

Financing Activities

Net cash provided by financing activities was $1.0 million for the nine months ended September 30, 2026, a decrease of $2.7 million as compared to $3.7 million of net cash provided by financing activities for the nine months ended September 30, 2025. The decrease in net cash provided by financing activities was primarily attributable to $1.0 million of proceeds from the exercise of 2025 Warrants during the nine months ended September 30, 2026, as compared to $4.8 million of proceeds from equity financings, primarily sales under the ELOC, during the nine months ended September 30, 2025.

​

Contractual Obligations

As of September 30, 2026, we did not have any material contractual obligations.

Off-Balance Sheet Arrangements

As of September 30, 2026, we did not have any off-balance sheet arrangements.

Critical Accounting Policies and Estimates

Our condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements of the Company included in our 2025 Annual Report. There have been no significant and material changes in our Critical Accounting Policies and Estimates since the 2025 Annual Report.

Recently Issued Accounting Standards

See Note 3 of the notes to our condensed consolidated financial statements included elsewhere in this Quarterly Report and Note 2 of the notes to our annual consolidated financial statements in the 2025 Annual Report for our assessment of recently issued and adopted accounting standards.

22

Emerging Growth Company and Smaller Reporting Company Status

We are an emerging growth company under the Jumpstart Our Business Startups Act (the “JOBS Act”). The JOBS Act provides that an emerging growth company can delay adopting new or revised accounting standards until such a time as those standards apply to private companies.

Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company”, we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis), (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation or (v) comply with any new or revised financial accounting standards that have different effective dates for public and private companies until those standards would otherwise apply to private companies. However, we have elected to opt out of this extended exemption period discussed in (v) and will therefore comply with new or revised accounting standards on the applicable dates on which the adoption of such standards is required for non-emerging growth companies. We may take advantage of these other exemptions until we cease to be an emerging growth company which will occur no later than December 31, 2026, which marks the last day of the fiscal year following the fifth anniversary of the date of our initial public offering of common equity securities. We will cease to be an emerging growth company prior to the end of such five-year period if we become a “large accelerated filer” as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended, or we issue more than $1.0 billion of non-convertible debt in any three-year period.

Additionally, we are a “smaller reporting company” as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will be able to take advantage of these scaled disclosures for so long as our voting and non-voting Common Stock held by non-affiliates is less than $250.0 million measured on the last business day of our second fiscal quarter, or our annual revenue is less than $100.0 million during the most recently completed fiscal year and our voting and non-voting Common Stock held by non-affiliates is less than $700.0 million measured on the last business day of our second fiscal quarter.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

Item 4. Controls and Procedures.

Limitations on Effectiveness of Controls and Procedures

In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, management has evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of September 30, 2026. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of September 30, 2026.

23

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended September 30, 2026, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

24

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we may become involved in actions, claims, suits and other legal proceedings arising in the ordinary course of our business, including assertions by third parties relating to intellectual property infringement, breaches of contract or warranties or employment-related matters. We are not currently a party to any actions, claims, suits or other legal proceedings the outcome of which, if determined adversely to us, would individually or in the aggregate have a material adverse effect on our business, financial condition, and results of operations.

Item 1A. Risk Factors

Our operations and financial results are subject to various risks and uncertainties, including those described in Part I, Item 1A, “Risk Factors” in the 2025 Annual Report, which could adversely affect our business, financial condition, results of operations, cash flows, and the trading price of our Common Stock. There have been no material changes in our risk factors since the 2025 Annual Report.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Director Grants

​

Pursuant to the Company’s policy for director compensation, the Company granted 4,210 RSUs to Daniel M. Friedberg and 2,105 RSUs to each of Margaret Chu, Stuart V. Flavin III, David Gow and Petros Kitsos, on September 30, 2026 for each director’s board and committee service during the third quarter of 2026, all of which immediately vested into shares of Common Stock on a one-for-one basis totaling 12,630 shares.

The offers, sales, and issuances of the securities pursuant to the grants were made in reliance upon the exemption from registration under Rule 506 promulgated under the Securities Act and/or under Section 4(a)(2) of the Securities Act.

​

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information

During the three months ended September 30, 2026, no director or “officer” (as defined in Rule 16a-1(f) of the Exchange Act) of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

25

Item 6. Exhibits

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Incorporated by Reference

​

​

​

​

​

​

​

​

​

​

Filed /

​

​

​

​

​

​

​

​

​

​

Furnished

Exhibit

  ​ ​ ​

Description

  ​ ​ ​

Form

  ​ ​ ​

Exhibit

  ​ ​ ​

Filing Date

  ​ ​ ​

Herewith

2.1†

​

Business Combination Agreement, dated as of December 5, 2022, by and among SportsMap Tech Acquisition Corp., Infrared Cameras Holdings, Inc., and ICH Merger Sub Inc.

​

8-K

​

2.1

​

12/6/2022

​

​

2.2

​

Amendment No. 1 to Business Combination Agreement, dated as of June 27, 2023, by and among SportsMap Tech Acquisition Corp., Infrared Cameras Holdings, Inc., and ICH Merger Sub Inc.

​

8-K

​

2.2

​

6/28/2023

​

​

2.3

​

Amendment No. 2 to Business Combination Agreement, dated September 17, 2023, by and among SportsMap Tech Acquisition Corp., Infrared Cameras Holdings, Inc., and ICH Merger Sub Inc.

​

8-K

​

2.2

​

9/20/2023

​

​

3.1

​

Second Amended and Restated Certificate of Incorporation of MultiSensor AI Holdings, Inc., as amended through April 8, 2026.

​

10-Q

​

3.1

​

5/13/2026

​

3.2

​

Second Amended and Restated Bylaws of MultiSensor AI Holdings, Inc.

​

10-K

​

3.2

​

3/28/2025

​

3.3

​

Certificate of Designations of the Powers, Preferences and Relative, Participating, Optional and Other Special Rights of Preferred Stock and Qualifications, Limitations and Restrictions Thereof of Series A Convertible Preferred Stock.

​

8-K

​

3.1

​

10/30/2025

​

​

4.1

​

Warrant Agreement, dated as of October 18, 2021, by and between the Registrant and Continental Stock Transfer & Trust Company, as warrant agent.

​

8-K

​

4.1

​

10/21/2021

​

​

4.2

​

Form of Financing Warrant.

​

8-K

​

10.3

​

12/01/2023

​

​

4.3

​

Form of Warrant.

​

8-K

​

4.1

​

10/30/2025

​

​

10.1

​

Form of Restricted Stock Unit Grant Notice and Award Agreement (Akram and Nadolny – 2023 Incentive Award Plan).

​

8-K

​

10.1

​

7/20/2026

​

​

10.2

​

Form of Performance Stock Unit Grant Notice and Award Agreement (Akram and Nadolny – 2023 Incentive Award Plan).

​

8-K

​

10.2

​

7/20/2026

​

​

10.3

​

First Amendment to Employment Agreement, dated July 16, 2026, by and between MultiSensor AI Holdings, Inc. and Asim Akram.

​

8-K

​

10.3

​

7/20/2026

​

​

10.4

​

Second Amendment to Amended and Restated Employment Agreement, dated July 16, 2026, by and between MultiSensor AI Holdings, Inc. and Robert Nadolny.

​

8-K

​

10.4

​

7/20/2026

​

​

31.1

​

Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer.

​

​

​

​

​

​

​

*

31.2

​

Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.

​

​

​

​

​

​

​

*

32.1

​

Section 1350 Certification of Chief Executive Officer.

​

​

​

​

​

​

​

**

32.2

​

Section 1350 Certification of Chief Financial Officer.

​

​

​

​

​

​

​

**

101.SCH

​

Inline XBRL Taxonomy Extension Schema Document.

​

​

​

​

​

​

​

*

101.CAL

​

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

​

​

​

​

​

​

​

*

101.DEF

​

Inline XBRL Taxonomy Extension Definition Linkbase Document.

​

​

​

​

​

​

​

*

26

101.LAB

​

Inline XBRL Taxonomy Extension Label Linkbase Document.

​

​

​

​

​

​

​

*

101.PRE

​

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

​

​

​

​

​

​

​

*

104

​

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

​

​

​

​

​

​

​

*

​

​

*

Filed herewith

**

Furnished herewith

†

Schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Registrant undertakes to furnish supplemental copies of any of the omitted schedules upon request by the SEC.

​

​

​

27

​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

​

MultiSensor AI Holdings, Inc.

Date: November 12, 2026

​

​

By:

/s/ Asim Akram

​

​

Asim Akram

​

​

Chief Executive Officer and President

​

​

(Principal Executive Officer)

Date: November 12, 2026

​

​

By:

/s/ Robert Nadolny

​

​

Robert Nadolny

​

​

Chief Financial Officer and Secretary

​

​

(Principal Financial Officer and

​

​

Principal Accounting Officer)

​

28

Keep reading